97155 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
Compositions and methods to improve anti-angiogenic therapy and immunotherapy
#302DETECTING CANCER WITH ANTI-CXCL13 AND ANTI-CXCR5 ANTIBODIES
#303DETECTION OF CHO-MIF CONTAMINATIONS
#304COMPOSITIONS, METHODS AND USES OF ALPHA 1-ANTITRYPSIN FOR EARLY INTERVENTION IN BONE MARROW TRANSPLANTATION AND TREATMENT OF GRAFT VERSUS HOST DISEASE
#305Mitigation and reversal of intestinal fibrosis and inflammation by inhibition of TL1A function
#306IP-10 antibodies and their uses
#307Human IL-23 Antigen Binding Proteins
#308METHOD FOR PREVENTING OR TREATING ATHEROSCLEROSIS
#309Fully humanized anti-platelet factor 4 antibodies that treat heparin-induced thrombocytopenia
#310Methods and compositions for delivering MRNA coded antibodies
#311Antibodies of the class IGG4
#312Optimized anti-TL1A antibodies
#313Use of anti-family with sequence similarity 19, member A5 antibodies for the treatment of glaucoma
#314Human antibodies to GREM1
#315PEPTIDES FOR USE IN TREATMENT AND DIAGNOSIS OF TYPE 1 DIABETES
#316BISPECIFIC ANTIBODIES
#317Use of anti-FAM19A5 antibodies for treating fibrosis
#318Nourin molecular biomarkers diagnose angina patients with negative troponin
#319Therapeutic immunoglobulin G4 for improved bioanalytical and bioprocessing properties
#320Pharmaceutical composition for prevention and/or treatment of atopic dermatitis comprising IL-31 antagonist as active ingredient
#321Compositions And Methods For Treating Cancer
#322Process for the purification of recombinant antibody fragments
#323Inhibition of Chemokine CCL7 or Receptor CCR3 of Same for the Treatment and Diagnosis of Prostate Cancer
#324Antigen Binding Proteins Capable of Binding Thymic Stromal Lymphopoietin
#325Immunoglobulin Variable Region Libraries
#326Stable anti-OSMR antibody formulation
#327Application of PDCD4 as a therapeutic target for antidepressants and/or anxiolytics drugs
#328Antigen binding molecules and methods of use thereof
#329Anti-EMAP II antibody and use thereof
#330Anti CCL24 (EOTAXIN2) antibodies for use in the treatment of hepatic diseases
#331Atomic description of immune complex that causes heparin-induced thrombocytopenia
#332Autophagy-related nourin gene-based RNA network as early biomarkers for cardiac patients
#333USE OF MONOCLONAL ANTIBODIES FOR THE TREATMENT OF INFLAMMATION AND BACTERIAL INFECTIONS
#334Disulfide-type HMGB1-specific antibody, method for measuring disulfide-type HMGB1 and kit for said measurement, and measurement method capable of quantitating all of HMGB1 molecules including reduced HMGB1, disulfide-type HMGB1 and thrombin-cleavable HMGB1 and kit for said measurement
#335NOVEL MONOCLONAL ANTIBODIES TO OSTEOPONTIN
#336Immunoglobulins and uses thereof
#337Anti-CcL8 antibodies and uses thereof
#338COMBINATION THERAPY FOR THE TREATMENT OF AUTOIMMUNE DISEASES
#339Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
#340IL-31 ANTIBODY COMPOSITIONS
#341HUMAN IL-23 ANTIGEN BINDING PROTEINS
#342Differential diagnosis of eczema and psoriasis
#343ANTI-RANKL ANTIBODIES AND METHODS OF USE
#344IL-13 antibody and preparation method and use thereof
#345Immunoglobulin single variable domains directed against macrophage migration inhibitory factor
#346MATERIAL AND METHODS FOR DIAGNOSING AND TREATING KAWASAKI DISEASE AND KLS
#347Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
#348Methods for treatment of cancer comprising TIGIT-binding agents
#349CCR3 inhibition for ocular angiogenesis and macular degeneration
#350Immunoglobulins and uses thereof
#351USES OF IL-41
#352Antibody specifically binding to IL-17A, encoding nucleic acid, and method of using the antibody
#353NANOPARTICLE FORMULATIONS AND METHODS OF MAKING AND USING THEREOF
#354METHODS OF INHIBITING METASTASIS IN CANCER
#355Treatment of SMC mediated disease
#356Antibodies against HMB1, and composition comprising same for treating or preventing alzheimer's disease
#357Methods for manufacturing activatable binding polypeptides comprising matrix metalloprotease cleavable moieties
#358Method of Modulating Fibroblast Accumulation or Collagen Deposition
#359Multispecific antigen binding proteins and methods of use thereof
#360Method of altering an antibody-related adverse event based on SCD163 and/or CXCL5 levels
#361ANTIBODIES TO M-CSF
#362ANTIBODY VARIANTS
#363Antibody or an antigen-binding fragment thereof capable of binding to a human receptor of interleukin-6
#364Methods of treating cognitive symptoms of an aging-associated impairment by modulating C-C chemokine receptor type 3 (CCR3)
#365Methods for producing antibodies promoting disappearance of antigens having plurality of biological activities
#366Filovirus antibody
#367Method of treating extracellular tissue and vascular calcification and arteriosclerosis
#368METHODS AND COMPOSITIONS FOR TREATING LUNG DISEASE OF PREMATURITY
#369Method for treating IL-8-related diseases
#370Anti-CXCR5 antibodies and compositions and uses thereof
#371Anti-human interleukin-17A monoclonal antibody
#372TREATMENT OF CANCER USING A CHIMERIC ANTIGEN RECEPTOR IN COMBINATION WITH AN INHIBITOR OF A PRO-M2 MACROPHAGE MOLECULE
#373Treatment of eosinophil or mast cell related disorders
#374Anti eotaxin-2 antibodies that recognize additional CCR3-binding chemokines
#375Emapii neutralizing antibody limits influenza A virus (IAV)-induced lung injury
#376Compositions comprising bacterial strains
#377Methods and pharmaceutical compositions for the treatment of pulmonary bacterial infections
#378Anti-jagged antibodies and methods of use
#379MARKER SEQUENCES FOR MANAGING THE THERAPY OF RHEUMATOID ARTHRITIS PATIENTS
#380Treatment of hippo pathway mutant tumors and methods of identifying subjects as candidates for treatment
#381Antibody recognizing human leukemia inhibitory factor (LIF) and use of anti-LIF antibodies in the treatment of diseases associated with unwanted cell proliferation
#382Anti-age antibodies for treating neurodegenerative disorders
#383Pharmaceutical composition comprising anti-human TSLP receptor antibody
#384Engineered immunoglobulins with altered FcRn binding
#385Human IL-23 Antigen Binding Proteins
#386Methods and compositions for delivering mRNA coded antibodies
#387Compositions and methods for treating Parkinson's disease
#388Antibody facilitating programmed necrosis of cells and application thereof
#389Stable anti-OSMR antibody formulation
#390Ion concentration-dependent binding molecule library
#391Method for Producing Antibodies
#392CCR3 MODULATION IN THE TREATMENT OF AGING-ASSOCIATED IMPAIRMENTS, AND COMPOSITIONS FOR PRACTICING THE SAME
#393Signatures and determinants for diagnosing infections and methods of use thereof
#394Triple combination antibody therapies
#395IL-12 P40 monomer, monoclonal antibody against P40 homodimer and the combination of the two for autoimmune disease treatment
#396Methods and compositions for treating multiple sclerosis
#397Anti-GM-CSF antibodies and uses thereof
#398NSP4 inhibitors and methods of use
#399Anti-GM-CSF antibodies and uses thereof
#400Pan-ELR+ CXC chemokine antibodies
#401Antigen binding dimer-complexes, methods of making/avoiding and uses thereof
#402Humanized anti-CLL-1 antibodies
#403METHOD FOR MODULATING APPETITE
#404Therapeutic combination and methods of treatment with a DLL4 antagonist and an anti-hypertensive agent
#405Method of manufacturing a protein by perfusion in media with a low amino acid concentration
#406Stable anti-OSMR antibody formulation
#407Conjugated C1 Esterase Inhibitor and Uses Thereof
#408Thymic stromal lymphopoietin (TSLP)-binding molecules and methods of using the molecules
#409Nucleic acids encoding anti-Factor P antibodies
#410Anti-canine TARC antibody used for treatment and diagnosis of canine atopic dermatitis
#411Monocyte modulation and control of tumor metastasis
#412Method and pharmaceutical composition for treating Crohn's disease
#413COMPOSITIONS AND METHODS FOR STEM CELL DELIVERY
#414Treatment of asthma with anti-TSLP antibody
#415COMBINATION THERAPY OF ANTI-MIF ANTIBODIES AND GLUCOCORTICOIDS
#416Chimeric antigen receptors, and T cells in which chimeric antigen receptor is expressed
#417IMMUNOGLOBULIN-LIKE MOLECULES DIRECTED AGAINST FIBRONECTIN-EDA
#418MEANS AND METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY DISORDERS
#419Methods of treating inflammation associated airway diseases and viral infections
#420Anti-S100A8 for treating leukemia
#421IMMUNOLOGICAL TEST METHOD AND IMMUNOLOGICAL TEST KIT
#422METHODS AND COMPOSITIONS FOR ENHANCING GENE EDITING
#423Polynucleotides encoding anti-CXCL13 antibodies
#424Compositions And Methods For Treating Cancer
#425Detection of CHO-MIF contaminations
#426Liquid formulation comprising GM-CSF neutralizing compound
#427PREVENTION OF METASTASIS AND RECURRENCE AFTER PRIMARY CANCER TREATMENT
#428Combination immunotherapy
#429Bispecific antibodies
#430TREATMENT OF CANCER BY COMBINED BLOCKADE OF THE PD-1 AND CXCR4 SIGNALING PATHWAYS
#431ANTI-CCL2 ANTIBODIES FOR TREATMENT OF SCLERODERMA
#432Future cardiac event biomarkers CCL3, CCL5, and CCL18
#433Method of Increasing GIPCR Signalization in the Cells of a Scoliotic Subject
#434Anti-CCL17 antibodies
#435Chimeric and humanized anti-histone antibodies
#436ANTI-MIF ANTIBODIES IN THE TREATMENT OF CANCERS CONTAINING MUTANT TP53 AND/OR MUTANT RAS
#437IL-31 ANTIBODY COMPOSITIONS
#438Phage display library, members thereof and uses of the same
#439Use of Macrophage inflammatory protein-1Beta (MIP-1Beta) inhibitor to protect pancreas and prevent blood sugar from rising
#440Human antibody specific for interleukin-1 alpha
#441Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
#442Immunoglobulins and uses thereof
#443Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
#444PHARMACEUTICAL COMPOSITION FOR TREATING RHEUMATOID ARTHRITIS
#445METHODS AND COMPOSITIONS FOR USING MHC CLASS II INVARIANT CHAIN POLYPEPTIDES AS A RECEPTOR FOR MACROPHAGE MIGRATION INHIBITORY FACTOR
#446METHOD FOR INHIBITING LYMPHANGIOGENESIS BY ADMINISTRATION OF AN INHIBITOR OF THE CXCL12 PATHWAY
#447COMPOSITION, METHOD AND KIT FOR PATHOLOGY
#448Polynucleotides encoding angiopoietin-2 (ang-2) binding polypeptides
#449Method for producing human monoclonal antibodies that binds to at least one part of HMGB1
#450Anti-IL-6 antibodies for the treatment of arthritis
#451ANTI-GREMLIN-1 (GREM1) ANTIBODIES AND METHODS OF USE THEREOF FOR TREATING PULMONARY ARTERIAL HYPERTENSION
#452Use of MIP-1Beta inhibitors for improving angiogenesis to reduce tissue ischemia and rescue diabetic vascular disease in diabetes mellitus
#453Compositions for regulating iron homeostasis and methods of using same
#454Methods and compositions for treating and/or preventing a disease or disorder associated with abnormal level and/or activity of the IFP35 family of proteins
#455Method of treating psoriasis with increased interval dosing of anti-IL12/23 antibody
#456STEM CELL FACTOR INHIBITOR
#457Atomic description of immune complex that causes heparin-induced thrombocytopenia
#458Methods for treating ischemic stroke using chimeric and humanized anti-histone antibodies
#459Antigen binding molecules and methods of use thereof
#460METHODS AND KITS FOR ANALYSIS OF HMGB1 ISOFORMS
#461INTERFERON ALPHA ANTIBODIES AND THEIR USES
#462Pan-ELR+ CXC chemokine antibodies
#463Anti-CXCL12 antibody molecules and their uses
#464Conjugated C1 Esterase Inhibitor and Uses Thereof
#465Compositions comprising bacterial strains
#466Anti-human IL-17 monoclonal antibodies and use thereof
#467Anti-TNF-α fully human monoclonal antibodies with low immunogenicity and application thereof
#468Dual Variable Domain Immunoglobulin and Uses Thereof
#469VH SCAFFOLD
#470Multivalent and monovalent multispecific complexes and their uses
#471Humanized CC chemokine receptor 4 (CCR4) antibodies and methods of use thereof
#472Antibodies to M-CSF
#473Production of proteins in labyrinthulomycetes
#474RSPO3 Binding Agents and Uses Thereof
#475Biomarkers and assay to detect chronic graft versus host disease
#476METHODS FOR TREATING CANCER
#477INHIBITION OF BONE RESORPTION WITH RANKL BINDING PEPTIDES
#478PHARMACEUTICAL ANTI-TNF-ALPHA ANTIBODY FORMULATION
#479USE OF ANTI-EOTAXIN ANTIBODIES FOR TREATING INFLAMMATORY BOWEL DISEASE
#480Immunoglobulin Variable Region Libraries
#481Composition for diagnosis of liver metastasis of colorectal cancer and the use thereof
#482Methods for treating thrombosis using chimeric and humanized anti-histone antibodies
#483CHARACTERIZATION OF CHO-MIF GENE AND PROTEIN, AND USE THEREOF
#484Medicament and apparatus for treating chronic kidney disease
#485Amino acid sequences directed against RANK-L and polypeptides comprising the same for the treatment of bone diseases and disorders
#486Therapeutic combination and methods of treatment with a DLL4 antagonist and an anti-hypertensive agent
#487IP-10 antibodies and their uses
#488Antigen binding proteins to oncostatin M (OSM)
#489VACCINES AND MONOCLONAL ANTIBODIES TARGETING TRUNCATED VARIANTS OF OSTEOPONTIN AND USES THEREOF
#490Inhibition of chemokine CCL7 or receptor CCR3 of same for the treatment and diagnosis of prostate cancer
#491Treatment of eosinophil or mast cell related disorders
#492Pharmaceutical use of FAM19A5 involved in regulating gliogenesis
#493Immunoglobulin variable domains
#494Uses of parasite macrophage migration inhibitory factors
#495Method of Modulating Fibroblast Accumulation or Collagen Deposition
#496Thymic stromal lymphopoietin (TSLP)-binding molecules and methods of using the molecules
#497Method for treating muscular dystrophy
#498ANTIGEN-BINDING MOLECULE PROMOTING DISAPPEARANCE OF ANTIGENS HAVING PLURALITY OF BIOLOGICAL ACTIVITIES
#499SPECIFIC SITES FOR MODIFYING ANTIBODIES TO MAKE IMMUNOCONJUGATES
#500Combination therapy for the treatment of autoimmune diseases
#501Antibodies against platelet-derived growth factor (PDGF)
#502Antibodies against glioma biomarkers
#503Human IL-23 antigen binding proteins
#504COMPOSITIONS, METHODS AND USES OF ALPHA 1-ANTITRYPSIN FOR EARLY INTERVENTION IN BONE MARROW TRANSPLANTATION AND TREATMENT OF GRAFT VERSUS HOST DISEASE
#505IDENTIFICATION OF CXCR8, A NOVEL CHEMOKINE RECEPTOR
#506Anti eotaxin-2 antibodies that recognize additional CCR3-binding chemokines
#507Immunoglobulin variable region libraries
#508Blockade of CCL18 signaling via CCR6 as a therapeutic option in treating interstitial lung disease
#509Anti-MIF immunohistochemistry
#510SDF-1 binding nucleic acids and the use thereof
#511Method for manufacturing digestive enzyme antibody and egg having same, and for manufacturing processed product containing egg as ingredient thereof and composition including antibody
#512METHOD FOR MODULATING APPETITE
#513ANTI-CCL2 ANTIBODIES FOR TREATMENT OF SCLERODERMA
#514Bicistronic expression vector for antibody expression and method for producing antibody using same
#515ANTI-CCL8 THERAPY FOR BREAST CANCER
#516TSLP Binding Proteins
#517Antibody targeting stem cell factor
#518Human antibodies against eotaxin and their use
#519Stem cell factor inhibitor
#520Antibodies to M-CSF
#521METHODS FOR PREVENTION AND TREATMENT OF INFLAMMATION USING ANTI-CHEMOKINE ANTIBODIES
#522NSP4 inhibitors and methods of use
#523TREATMENT OF DIABETES MELLITUS, METHODS AND COMPOSITIONS THEREFOR
#524CCR3 MODULATION IN THE TREATMENT OF AGING-ASSOCIATED IMPAIRMENTS, AND COMPOSITIONS FOR PRACTICING THE SAME
#525Method of treatment of pain by administration of a CCL17 specific antibody
#526Methods for Modulation of Autophagy Through the Modulation of Autophagy-Inhibiting Gene Products
#527Methods of treating inflammation associated airway diseases and viral infections
#528USE OF MONOCLONAL ANTIBODIES FOR THE TREATMENT OF INFLAMMATION AND BACTERIAL INFECTIONS
#529ANTIBODIES AGAINST MONOCYTE CHEMOTACTIC PROTEINS
#530Ang-2-binding modular recognition domain complexes and pharmaceutical compositions thereof
#531Antigen binding proteins capable of binding thymic stromal lymphopoietin
#532Pan-ELR CXC chemokine antibodies
#533Myonectin (CTRP15), compositions comprising same, and methods of use
#534BIOMARKERS FOR THE DIAGNOSIS AND THE RESPONSE TO TREATMENT OF PANCREATIC CANCER
#535ANTI-CXCL9, ANTI-CXCL10, ANTI-CXCL11, ANTI-CXCL13, ANTI-CXCR3 AND ANTI-CXCR5 AGENTS FOR INHIBITION OF INFLAMMATION
#536Methods for treating sepsis using chimeric and humanized anti-histone antibodies
#537Activatable binding polypeptides and methods of identification and use thereof
#538RSPO3 binding agents and uses thereof
#539Anti-TNF-α/CXCL10 double-targeting antibody and use thereof
#540Anti-CXCL1, CXCL7 and CXCL8 antibodies and their applications
#541Antibodies against the S100P protein for the treatment and diagnosis of cancer
#542Anti-CCL2 and anti-LOXL2 combination therapy for treatment of scleroderma
#543Identifying affinity-matured human antibodies
#544Identifying affinity-matured human antibodies
#545Treatment and reversal of fibrosis and inflammation by inhibition of the TL1A-DR3 signaling pathway
#546MAST CELL MARKERS AND PREVENTION, DIAGNOSIS, AND THERAPY FOR CHRONIC PELVIC PAIN SYNDROME
#547THYMIC STROMAL LYMPHOPOIETIN FRAGMENTS AND USES THEREOF
#548Neutralizing anti-CCL20 antibodies
#549EGFR-binding modular recognition domains
#550COMPOSITIONS FOR INHIBITING INFLAMMATION IN A SUBJECT WITH A SPINAL CORD INJURY AND METHODS OF USING THE SAME
#551Methods and arrays for use in the same
#552Anti-RANKL antibodies and methods of use
#553Methods and compositions for delivering mRNA coded antibodies
#554Human antibody specific for interleukin-1alpha
#555Human antibodies to GREM1
#556ANTI-CXCL13 ANTIBODIES AND ASSOCIATED EPITOPE SEQUENCES
#557THERAPEUTIC AGENT
#558Methods of diagnosing, treating and monitoring diabetic retinopathy
#559Methods for increasing immunoglobulin A levels
#560ANTIBODIES DIRECTED AGAINST PYROGLUTAMATE MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1 N1PE)
#561Humanized anti-HMGB1 antibody or antigen-binding fragment thereof
#562Isolated anti-IL-6 antibodies
#563Antagonistic human light-specific human monoclonal antibodies
#564HMGI ANTIBODY FOR TREATING INFLAMMATORY CONDITIONS
#565MULTISPECIFIC ANTIBODIES
#566Liquid formulation comprising GM-CSF neutralizing compound
#567Epitope of IP-10 and antibody to same
#568MATERIAL AND METHODS FOR DIAGNOSING AND TREATING KAWASAKI DISEASE AND KLS
#569Anti-jagged antibodies and methods of use
#570INHIBITION OF TH17 CELLS MIGRATION TO INFLAMED TISSUES USING ANTIBODIES DIRECTED AGAINST MCAM
#571Treatment of brain cancers using central nervous system mediated gene transfer of monoclonal antibodies
#572Method of manufacturing a protein by perfusion in media with a low amino acid concentration
#573Composition comprising material for inhibiting SCF or receptor thereof for treating or preventing diseases associated with vascular permeability
#574Anti-TGF-β induction of bone cell function and bone growth
#575METHOD FOR MODULATING APPETITE
#576Monoclonal antibody binding specifically to DLL4 and use thereof
#577ANTIKINE ANTIBODIES THAT BIND TO MULTIPLE CC CHEMOKINES
#578Methods and Compositions for Treating or Diagnosing Melanoma
#579ANTI-CCL2 ANTIBODIES FOR TREATMENT OF SCLERODERMA
#580Compositions comprising antibodies targeting factor P
#581Method for treating muscle wasting syndrome using antagonist antibodies against GDF-8
#582Methods of treating rapidly progressive glomerulonephritis using chimeric and humanized anti-histone H4 antibodies
#583Use of SDF-1 to improve ischemic myocardial function
#584USES OF CXCL17, A NOVEL CHEMOKINE MARKER OF HUMAN LUNG AND GASTROINTESTINAL DISEASE
#585Use of blocking agents of bone morphogenic protein (BMP) signalling for the treatment of neuroinflammatory and neurodegenerative diseases
#586Single-chain antibodies and other heteromultimers
#587Method for producing human monoclonal antibodies that binds to at least one part of HMGB1
#588Methods for the treatment of B cell-mediated inflammatory diseases
#589Anti-CCL17 antibodies
#590Therapeutic combination and methods of treatment with a DLL4 antagonist and an anti-hypertensive agent
#591Pharmaceutical use of FAM19A5 involved in regulating gliogenesis
#592Antibodies against the CXC-ELR family of chemokines
#593IP-10 antibodies and their uses
#594IL-19 AS A BIOMARKER OF TSLP TREATMENT
#595Stabilised protein solutions
#596TREATMENT OF ACUTE INFLAMMATION IN THE RESPIRATORY TRACT
#597Anti-RANTES Antibodies
#598Method of treating cancer
#599Antigen binding proteins to Oncostatin M (OSM)
#600DETECTION AND MODULATION OF RHEUMATOID ARTHRITIS